United States · Venture startup
5 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 5 rounds since 2010, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $4.0M sold, first sale Nov 2018
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Sept 2015
Mercury Fund
Fletcher Spaght, Inc.
Renaissance Venture Capital FundReported by finsmes.comSEC filing: $7.0M sold, first sale Oct 2013
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Feb 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Mercury Fund
Draper AssociatesFletcher Spaght, Inc.Renaissance Venture Capital FundRenaissance Capital Manitoba Ventures FundMissing a round, or an investor who was in one? Tell us.
Swift Biosciences's investors include Mercury Fund, Draper Associates, Fletcher Spaght, Inc., Renaissance Venture Capital Fund and Renaissance Capital Manitoba Ventures Fund.
Swift Biosciences has raised $16M across 5 rounds since 2010.
Swift Biosciences's most recent round was a Venture of $4.0M in Nov 2018.
Swift Biosciences's largest round on record is $7.0M (Series B), in Oct 2013.
Swift Biosciences's first round on record, in Aug 2010, was backed by Mercury Fund.
Swift Biosciences's latest named round is a Venture, in Nov 2018.
Swift Biosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
